# OnCo record flt3-itd (biomarker). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/biomarkers/flt3-itd/>
  a schema:MedicalTest ;
  onco:kind "biomarker" ;
  schema:identifier "flt3-itd" ;
  schema:name "FLT3-ITD (internal tandem duplication)"@en ;
  schema:alternateName "FLT3-ITD"@en, "FLT3 ITD"@en, "FLT3 internal tandem duplication"@en, "FLT3-ITD positive"@en, "FLT3-ITD allelic ratio"@en, "ITD-positive AML"@en ;
  schema:description "FLT3-ITD is a duplicated stretch of the FLT3 receptor gene found in about a quarter of acute myeloid leukaemias; it makes relapse more likely and is treated with midostaurin, quizartinib or gilteritinib."@en ;
  schema:url <https://onco.cc/biomarkers/flt3-itd/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29cdbcfe-497d-4e78-bb7b-2d4acafe8e86>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11fa3fc9-6776-49a6-b1c1-653f627c3e58> ;
  onco:tag "biomarker", "flt3" ;
  onco:related <https://onco.cc/biomarkers/flt3-tkd/>, <https://onco.cc/biomarkers/npm1-mutation/> ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/aml-flt3/> ;
  onco:drugs <https://onco.cc/drugs/midostaurin/>, <https://onco.cc/drugs/quizartinib/>, <https://onco.cc/drugs/gilteritinib/> ;
  onco:terms <https://onco.cc/terms/flt3-itd-allelic-ratio/> .